Janus Henderson Group
BVS icon

Janus Henderson Group’s Bioventus BVS Stock Holding History

Janus Henderson Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,200
Closed -$114K – 2412
2025
Q2 		$114K Hold
17,200
– – ﹤0.01% 2388
2025
Q1 		$155K Hold
17,200
– – ﹤0.01% 2416
2024
Q4 		$181K Buy
+17,200
New +$203K ﹤0.01% 2455

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group's BVS Position: Q3 2025 in Review

Janus Henderson Group sold out of Bioventus (BVS) in Q3 2025, closing a stake of 17,200 shares — an estimated $114K sold.

Janus Henderson Group first reported a position in BVS in Q4 2024 and held it in 3 quarters. The position peaked at $181K in Q4 2024. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • Janus Henderson Group reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • Janus Henderson Group sold 17,200 Bioventus shares in Q3 2025, an estimated $114K.
  • Janus Henderson Group first reported a position in Bioventus in Q4 2024 and held it in 3 quarters.
  • Janus Henderson Group's Bioventus position peaked at $181K in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Janus Henderson Group's 13F filing for Q3 2025, filed 14 Nov 2025.